PER 0.00% 10.0¢ percheron therapeutics limited

Ann: MHRA approval for ATL1102 Phase IIb DMD clinical trial in UK, page-26

  1. 3,006 Posts.
    lightbulb Created with Sketch. 504
    You're forgetting this is ANP - any positive announcements have the opposite effect!

    $5 in time.......!

    GLTAH's
    .
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.